Home
Products
Medical Simulation
Testing Equipments
Testing System
Testing Services
Blog
Showcase
Product Introduction
Product Video
Industry News
About
Company Overview
Technical Highlights
Contact
Contact Information
Leave a Message
Flagship Full-Body Arteriovenous Intervention Vascular Model—Transparent, Elastic Silicone with Customization Options
Cardiovascular health is a core component of overall human well-being, directly influencing an individual’s quality of life and life expectancy. Cardiovascular diseases—including coronary heart disease, hypertension, stroke, and others—have become the leading cause of death among China’s population. With rapid economic growth and profound changes in lifestyle, the incidence and mortality rates of cardiovascular diseases have been steadily rising, imposing a heavy health and economic burden on both society and individuals. In China, CVD ranks first among the causes of death for urban and rural residents, accounting for 48.98% of deaths in rural areas and 47.35% in urban areas in 2021. In fact, out of every 5 deaths, 2 are attributable to CVD.
View All
In May 2024, at the invitation of the Neurointerventional Hemodynamics Research Group at Stanford University in the United States.
In May 2024, at the invitation of the Neurointerventional Hemodynamics Research Group at Stanford University in the U.S., Derui Medical successfully completed the delivery of its next-generation bionic cerebral vascular phantom and advanced hemodynamic testing equipment. The system has received unanimous praise from both Stanford University and leading neurointerventional physicians in the U.S., addressing critical challenges encountered during cerebral vascular intervention procedures.
In June 2023, DeWei Medical successfully delivered the cardiac intervention device delivery testing system to HeartPath Medical Technology (Guangzhou) Co., Ltd.
In June 2023, Dermed Medical successfully delivered the cardiac intervention device delivery testing system to Heartway Medical Technology (Guangzhou) Co., Ltd., a rising star in China's cardiac intervention device industry.
In April 2023, DeWei Medical successfully delivered the ECMO mock-up testing system to the Human Pulmonary Circulation Project Team at Fuwai Hospital, Chinese Academy of Medical Sciences.
In April 2023, DeWei Medical successfully delivered the ECMO phantom testing system to the Human Pulmonary Circulation Project Team at Fuwai Hospital, Chinese Academy of Medical Sciences, completing China's first-ever in-vitro validation experiment for ECMO equipment—and addressing a key scientific challenge encountered during ECMO cannulation procedures.
In November 2022, Derui Medical successfully developed a particle/re-transmission testing system for pan-vascular interventional devices.
In November 2022, DeWei Medical successfully developed a particle/re-coating testing system for pan-vascular interventional devices. This solution addresses the critical need for in-vitro particle and re-coating validation of various pan-vascular interventional tools, including drug-coated balloons, drug-eluting stents, coated catheters, and coated guidewires.
Request a quote
*Please keep your phone accessible—we'll reach out to you within 24 hours.